514 Episodes

  1. S6 Ep13: Roychowdhury Relays Impact of Recent Infigratinib Approval in FGFR+ Cholangiocarcinoma

    Published: 11/29/2021

  2. S6 Ep12: Katona Highlights the Hallmarks of Hereditary Diffuse Gastric Cancer

    Published: 11/25/2021

  3. S6 Ep11: Marvels in Medicine: Allison Talks Everything from Advances in Immunotherapy to Jamming With Willie Nelson

    Published: 11/22/2021

  4. S6 Ep10: Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC

    Published: 11/18/2021

  5. S6 Ep9: Ku Reviews Exciting ESMO Data in Gastric/GEJ Cancer

    Published: 11/15/2021

  6. S6 Ep8: Gradishar Gives Insight Into the Growing Role of SERDs in Breast Cancer

    Published: 11/11/2021

  7. S6 Ep7: Tagawa Breaks Down FGFR Testing and the Use of Erdafitinib in Bladder Cancer

    Published: 11/8/2021

  8. S6 Ep6: Yarchoan Talks Research Directions in Fibrolamellar Carcinoma

    Published: 11/4/2021

  9. S6 Ep5: FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory B-ALL

    Published: 11/1/2021

  10. S6 Ep4: Jain and Spaggiari Speak to Surgical and Systemic Considerations for CRC Liver Metastases

    Published: 10/28/2021

  11. S6 Ep3: Johnson Previews the Potential Utility of VS-6766 Plus Defactinib in KRAS+ NSCLC

    Published: 10/25/2021

  12. S6 Ep2: Abid on Optimizing COVID-19 Vaccines in CAR T-Cell Therapy Recipients

    Published: 10/21/2021

  13. S6 Ep1: Ilson Delves Into the Development of Checkpoint Inhibition in Gastric/GEJ Cancers

    Published: 10/18/2021

  14. S5 Ep50: Gordan on Growing the Infrastructure for In-House Genomic Testing

    Published: 10/14/2021

  15. S5 Ep49: DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology

    Published: 10/11/2021

  16. S5 Ep48: Moore Voices Excitement With VS-6766 Plus Defactinib in Ovarian Cancer

    Published: 10/7/2021

  17. S5 Ep47: FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC

    Published: 10/4/2021

  18. S5 Ep46: Genomically Guided Radiation Dosing in Oncology: Ready for Prime Time?

    Published: 9/30/2021

  19. S5 Ep45: Aggarwal and Girard Analyze Data Amassed With Durvalumab in Unresectable Stage III NSCLC

    Published: 9/27/2021

  20. S5 Ep44: Monk Talks Tisotumab Vedotin and Exciting ESMO Data in Cervical Cancer

    Published: 9/23/2021

24 / 26